The Role of Factor Xa Anticoagulation in the Treatment of Venous and Arterial Diseases



Date & Location
Friday, February 28, 2020, 12:00 AM - Sunday, February 28, 2021, 11:59 PM

Credits
AMA PRA Category 1 Credits™ (1.00 hours), AMA PRA Category 1 Credits™ Designated (1.00 hours)

Target Audience
Specialties - Cardiology, Cardiovascular Health and Disease, Neurology and Rehabilitation, Nursing, Radiology, Vascular

Overview

On-Demand Webcast about Factor Xa Anticoagulant for Venous and Arterial Diseases.


Registration

To be eligible for credit, participants must complete the online activity, a post-test assessment, and the evaluation by February 25, 2021. Upon completing the activity, there will be instructions on how to print a certificate or other documentation of credit.

Release Date: February 25, 2020
Expiration Date: February 25, 2021

Estimated Time to Complete: 1 hour

There is no fee associated with this activity.


Objectives
As a result of participating in this activity, participants should be able to:

  1. Identify the clinical and socioeconomic factors that contribute to the public health burden associated with venous and arterial diseases
  2. Describe the Xa inhibitor mechanism of action and the associated rationale for its use in VTE and PAD management
  3. Evaluate the clinical evidence and current guidelines surrounding the use of Xa inhibitors for the short-, long-term, and extended prophylaxis of VTE and PAD across care settings
  4. Integrate the latest guidance and clinical data into interdisciplinary, patient-centric care plans for the use of Xa inhibitors in treatment and prevention of VTE and PAD

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and North American Center for Continuing Medical Education (NACCME). The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

The University of Cincinnati designates this enduring material activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Additional Information

The opinions expressed during the live activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees professional development.